Every one of those 1 sits in a single category, market-trends. Epigenetic Clocks is most often covered alongside Haleon, which appears in 1 of these 1 story. Each story carries 57 original sources on average, compared with 4.1 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Epigenetic Clocks
Every one of those 1 sits in a single category, market-trends. Epigenetic Clocks is most often covered alongside Haleon, which appears in 1 of these 1 story. Each story carries 57 original sources on average, compared with 4.1 for the broader beat in this window. The 5 average consequence score is below the beat benchmark of 6 in the same window. We currently track 1 Healthcare story that mention Epigenetic Clocks, all published on March 9, 2026.
Stories tracked
1
Sources per story
57
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 30 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Epigenetic Clocks. Shared-story counts are live from our verified record — not editorial picks.
Widespread clinical reporting suggests that daily multivitamin supplementation can significantly decelerate biological aging in older adults. This finding marks a major shift in the clinical validation of supplements for longevity and preventative healthcare.